Donald H. Atha

National Institute of Standards and Technology

Papers

Total Citations

H-Index

About

Donald H. Atha has dedicated his research career to advancing the early detection of cancer through the analytical validation of telomerase as a critical biomarker. His work focuses on the development and standardization of high-throughput assays for telomerase activity, an enzyme expressed in 85–90% of all human cancers but absent in normal somatic tissues. Atha’s most cited paper, “Analytical Validation of Telomerase Activity for Cancer Early Detection” (2004, 30 citations), established rigorous frameworks for ensuring the reliability of telomerase measurements in clinical settings. He further pioneered the use of capillary electrophoresis for high-throughput telomerase analysis (2003, 23 citations), enabling faster and more sensitive detection from easily obtained body fluids. His efforts to create candidate reference materials for telomerase assays (2005, 18 citations) addressed a critical need for standardization, paving the way for noninvasive, cost-effective cancer screening tools. By bridging analytical chemistry and oncology, Atha has laid essential groundwork for translating telomerase-based diagnostics from the lab to the clinic, offering hope for earlier, more accessible cancer detection.